Craft

Immunai

Market Valuation

$1.2 B

2021-10-27

Total Funding

$295 M

Immunai Summary

Company Summary

Overview
Immunai is a company that develops immune system technology. It specializes in platform, data, and therapeutics to identify, validate, and develop novel therapeutic candidates that act on the immune system to reverse disease and dysfunction. The company's platform uses vocabularies, quality control, cell-type annotation, data normalization, and peer review by domain experts, and enables machine learning and interpretation of biological phenomena.
Type
Private
Status
Active
Founded
2018
HQ
New York, NY, US | view all locations
Website
https://www.immunai.com
Cybersecurity rating
Sectors

Key People

  • Noam Solomon
  • Ansuman Satpathy

    Ansuman Satpathy, Scientific Co-Founder

  • Danny Wells

    Danny Wells, Scientific Co-Founder

  • Dan Littman

    Dan Littman, Scientific Co-Founder

    Operating MetricsView all

    Trademark Applications

    3

    Feb, 2021

    LocationsView all

    5 locations detected

    • New York, NY HQ

      United States

      430 E 29th St

    • Prague, Hlavní město Praha

      Czech Republic

      Václavské náměstí 841/3

    • Ness Ziona, Center District

      Israel

      Rehovot Kiryat Weizmann Science Park Pinhas Sapir Street 3

    • Tel Aviv, Tel Aviv District

      Israel

      14 Weitzman Street

    • Zurich, ZH

      Switzerland

      Hohlstrasse 515

    Footer menu